Mapping Public Attitudes Toward Psychedelics: Insight from the RAND Study – Drug Science
Comments Off on Mapping Public Attitudes Toward Psychedelics: Insight from the RAND Study – Drug Science
April 14, 2026
Understanding public attitudes toward psychedelics is crucial for advancing clinical implementation and patient access. The RAND study provides valuable insights into societal perceptions of psychedelic therapies. These attitudes influence policy…
‘I don’t want to go to opioids’: Texans worry about managing chronic pain amid hemp crackdown
Comments Off on ‘I don’t want to go to opioids’: Texans worry about managing chronic pain amid hemp crackdown
March 30, 2026
Opioid alternatives chronic pain management is a growing concern for Texans amid the hemp crackdown. Patients worry about losing access to hemp-derived cannabinoids they prefer over opioids. This regulatory shift forces many to reconsider their pain…
Schaumburg Family Advocates for Medical Cannabis Policy Improvements
Comments Off on Schaumburg Family Advocates for Medical Cannabis Policy Improvements
March 28, 2026
Medical cannabis policy evolution is driven by ongoing patient advocacy efforts. The Schaumburg family continues to push for improvements in state and federal laws. These changes directly impact clinical access and treatment options for patients.